Schering-Plough Corporation: New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day

KENILWORTH, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced the introduction of CLARITIN 12-Hour, the only 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour lasts all day and provides effective, non-drowsy relief from the worst indoor and outdoor allergy symptoms. The product is available for adults and children ages six and up.

"New CLARITIN 12-Hour offers the proven allergy relief people have relied on for years, with the added flexibility for people who want more control of their treatment," said Dr. John O'Mullane, group vice president, research and development, Schering-Plough Consumer Health Care. "Allergy sufferers can choose to treat their allergy symptoms for 12 or 24 hours depending on their individual needs."

CLARITIN 12-Hour, which comes in convenient RediTabs(R) tablets, is great for people on the go since they dissolve quickly without water (2). It is also convenient for moms looking to give their kids all day allergy relief, while allowing the flexibility to re-dose at night, if needed.

(1) 2007 Millward Brown Study

(2) Speed of dissolution does not imply speed of relief.

Finally, CLARITIN Eye is an antihistamine eye drop found in the eye care aisle that works in minutes and relieves the itch of allergy eyes for up to 12 hours.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SOURCE Schering-Plough Corporation




CONTACT: Media, Julie Lux, +1-908-298-4774, or cell, +1-908-216-0370, or
Investors, Janet M. Barth, or Joe Romanelli, both for Schering-Plough,
+1-908-298-7436

Web site: http://www.schering-plough.com/

Back to news